DHCNI Financials
DHCNI Stock | USD 14.86 0.22 1.46% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.62 | 1.2029 |
|
| |||||
Current Ratio | 12.05 | 11.4729 |
|
|
Investors should never underestimate DHCNI's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor DHCNI's cash flow, debt, and profitability to make informed and accurate decisions about investing in DHCNI.
Net Income |
|
DHCNI | Select Account or Indicator |
Understanding current and past DHCNI Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DHCNI's financial statements are interrelated, with each one affecting the others. For example, an increase in DHCNI's assets may result in an increase in income on the income statement.
DHCNI Stock Summary
DHCNI competes with Diversified Healthcare, Brighthouse Financial, Office Properties, QVCC, and QVC 6375. DHCNI is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Energy, Energy |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 81721M208 25525P206 |
Sector | Oil, Gas & Consumable Fuels |
Industry | Energy |
Benchmark | Dow Jones Industrial |
Currency | USD - US Dollar |
DHCNI Key Financial Ratios
Revenue | 1.41 B | |||
EBITDA | 207.3 M | |||
Net Income | (293.57 M) | |||
Total Asset | 5.45 B | |||
Retained Earnings | (2.28 B) |
DHCNI Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.7B | 6.5B | 6.6B | 6.0B | 5.4B | 4.2B | |
Net Debt | 3.5B | 3.5B | 3.0B | 2.4B | 2.6B | 1.9B | |
Cash | 37.4M | 74.4M | 634.8M | 658.1M | 245.9M | 258.2M | |
Other Assets | 6.1B | 6.1B | 5.7B | 5.1B | 75.3M | 71.5M | |
Net Receivables | 2.0M | 104.8M | 82.1M | 8.7M | 81.4M | 85.5M | |
Total Liab | 3.8B | 3.9B | 4.0B | 3.4B | 3.1B | 2.1B | |
Total Current Assets | 261.8M | 203.3M | 1.0B | 688.7M | 262.5M | 146.8M | |
Common Stock | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 1.6M | |
Other Current Liab | 30.8M | (275.9M) | (770.2M) | (670.6M) | 22.9M | 24.0M | |
Retained Earnings | (1.9B) | (2.1B) | (2.0B) | (2.0B) | (2.3B) | (2.2B) | |
Inventory | 276.7M | 114.9M | 1.4B | (8.7M) | (10.0M) | (9.5M) | |
Other Current Assets | (54.2M) | (90.8M) | 382.1M | 39.3M | 16.6M | 30.8M | |
Short Term Debt | 537.5M | 303.2M | 800M | 700M | 1.8M | 1.7M | |
Long Term Debt | 3.7B | 3.5B | 3.0B | 3.5B | 4.0B | 3.2B | |
Long Term Debt Total | 3.7B | 3.5B | 3.0B | 3.5B | 4.0B | 3.2B | |
Capital Surpluse | 4.6B | 4.6B | 4.6B | 4.6B | 5.3B | 4.7B | |
Intangible Assets | 337.9M | 286.5M | 48.7M | 45.4M | 33.9M | 32.3M |
DHCNI Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 1.0B | 1.6B | 1.4B | 1.3B | 1.4B | 1.5B | |
Gross Profit | 551.1M | 395.7M | 291.4M | 174.5M | 236.2M | 345.5M | |
Operating Income | 226.0M | 113.2M | 6.8M | (75.3M) | 4.1M | 3.9M | |
Ebit | 226.0M | (1.1B) | (748.5M) | (1.2B) | (76.8M) | (72.9M) | |
Ebitda | 515.0M | 383.3M | 708.2M | 164.0M | 207.3M | 332.4M | |
Net Income | (83.3M) | (134.3M) | 174.5M | (21.8M) | (293.6M) | (278.9M) | |
Income Tax Expense | 436K | 1.3M | 1.4M | 710K | 445K | 422.8K | |
Interest Expense | 180.1M | 201.5M | 255.8M | 209.4M | 191.8M | 137.0M | |
Income Before Tax | (82.8M) | (133.1M) | 181.4M | (21.1M) | (272.7M) | (259.0M) | |
Cost Of Revenue | 489.1M | 1.2B | 1.1B | 1.1B | 1.2B | 1.2B |
DHCNI Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (17.8M) | 38.6M | 926.1M | (328.6M) | (441.3M) | (419.3M) | |
Free Cash Flow | 265.8M | 158.5M | (63.3M) | (40.4M) | 10.5M | 11.0M | |
Depreciation | 282.2M | 262.7M | 263.9M | 239.5M | 284.1M | 151.4M | |
Dividends Paid | 199.7M | 42.8M | 9.5M | 9.6M | 9.6M | 9.1M | |
Capital Expenditures | 273.1M | 185.6M | 227.6M | 299.4M | 235.0M | 283.5M | |
Net Income | (82.9M) | (134.3M) | 179.9M | (15.8M) | (293.6M) | (278.9M) | |
End Period Cash Flow | 52.2M | 90.8M | 1.0B | 688.3M | 247.0M | 259.3M | |
Other Non Cash Items | 117.4M | 43.3M | (442.1M) | (265.7M) | 47.8M | 50.2M |
DHCNI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DHCNI's current stock value. Our valuation model uses many indicators to compare DHCNI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DHCNI competition to find correlations between indicators driving DHCNI's intrinsic value. More Info.DHCNI is one of the top stocks in number of shares shorted category among its peers. It is rated # 3 in revenue category among its peers totaling about 730,730 of Revenue per Number Of Shares Shorted. As of now, DHCNI's Total Revenue is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DHCNI's earnings, one of the primary drivers of an investment's value.DHCNI Systematic Risk
DHCNI's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DHCNI volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on DHCNI correlated with the market. If Beta is less than 0 DHCNI generally moves in the opposite direction as compared to the market. If DHCNI Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DHCNI is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DHCNI is generally in the same direction as the market. If Beta > 1 DHCNI moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in DHCNI Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DHCNI's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of DHCNI growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
DHCNI December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DHCNI help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DHCNI. We use our internally-developed statistical techniques to arrive at the intrinsic value of DHCNI based on widely used predictive technical indicators. In general, we focus on analyzing DHCNI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DHCNI's daily price indicators and compare them against related drivers.
Downside Deviation | 1.59 | |||
Information Ratio | (0.04) | |||
Maximum Drawdown | 9.84 | |||
Value At Risk | (2.36) | |||
Potential Upside | 2.7 |
Complementary Tools for DHCNI Stock analysis
When running DHCNI's price analysis, check to measure DHCNI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DHCNI is operating at the current time. Most of DHCNI's value examination focuses on studying past and present price action to predict the probability of DHCNI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DHCNI's price. Additionally, you may evaluate how the addition of DHCNI to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |